See the factory by live video walkthrough
Book an on-site factory visit in Guangzhou
When building an anti‑aging eye cream, the choice between retinal (retinaldehyde) and retinol can define your product’s efficacy story, stability profile, and cost structure. Both are vitamin A derivatives that convert to retinoic acid…
When building an anti‑aging eye cream, the choice between retinal (retinaldehyde) and retinol can define your product’s efficacy story, stability profile, and cost structure. Both are vitamin A derivatives that convert to retinoic acid in the skin, but they sit at different steps in the conversion chain. That single‑step difference ripples through performance claims, formulation complexity, and price positioning. This guide breaks down what buyers and brand owners need to evaluate when choosing between retinal and retinol for an eye cream.
Retinol (vitamin A alcohol) must oxidise to retinaldehyde, then further oxidise to retinoic acid before binding to nuclear receptors. Retinal (retinaldehyde) skips the first step, so it is one enzymatic conversion away from the active form. In theory, retinal works faster and more potently than retinol at equal concentrations. In practice, that potency also makes stability and irritation harder to manage—especially around the eyes.
| Attribute | Retinol | Retinal |
|---|---|---|
| Conversion steps to retinoic acid | 2 | 1 |
| Typical use concentration in eye creams | 0.02%–0.1% | 0.01%–0.05% |
| Relative speed of action | Gradual (weeks to visible results) | Faster (often faster visible improvement) |
| Stability in formulation | Moderate; requires antioxidants and protective packaging | Lower; more prone to oxidation, often needs encapsulation |
| Irritation potential at equivalent efficacy | Lower per unit of biological effect | Higher per unit, but lower use concentrations can offset this |
| Raw material cost (relative scale) | $$ | $$$ |
| Regulatory acceptance (US/EU) | Widely accepted | Accepted as cosmetic ingredient; some markets require careful claim substantiation |
Both retinoids degrade under light, heat, and oxygen, but retinal is notoriously more reactive. For an eye cream, which often comes in a jar or airless pump, degradation can lead not only to loss of efficacy but also to discoloration and a rancid odour that consumers will notice immediately.
Retinal raw material can cost 5 to 10 times more than retinol per kilo, and that multiple often widens when you factor in encapsulation and the testing needed to prove stability. However, because retinal is effective at lower concentrations, the in‑jar cost per unit may still be manageable—especially if you are targeting a premium, “derm‑grade” positioning.
A basic 15 ml retinol eye cream at 0.05% might have an active‑ingredient cost of a few cents per unit. The same product with 0.03% encapsulated retinal could cost 5–8 times more for the retinoid portion alone, pushing you toward a higher retail price point. Brands using retinal typically position the product as a prestige alternative to retinol, frequently with shorter‑time‑to‑results messaging.
Eye skin is thinner and more prone to irritation than facial skin, so the choice of retinoid sends a strong market signal.
In either case, the eye cream must pass ophthalmologist‑testing (or at least a RIPT and a separate peri‑ocular irritation study) to claim “suitable for the eye area.” Retinal formulas need extra scrutiny because the unencapsulated form can cause transient redness that consumers will misread as an allergic reaction.
When you go to a contract manufacturer with a retinal eye cream brief, these points give you leverage:
Technically possible, but the added complexity rarely translates into a consumer‑perceptible benefit. The blend would need separate encapsulation systems to prevent degradation, and the stability program becomes exponentially more expensive. Most brands pick one and build the supporting claims around it.
Neither is naturally derived in the strict sense—both are synthetic. However, retinal is sometimes sourced via biofermentation, which can support certain “natural origin” or “biotech” narratives. If clean beauty is core to your positioning, ask the manufacturer for the ISO 16128 natural origin index of the specific retinoid batch.
Under refrigeration or with a tightly sealed airless pump, well‑formulated encapsulated retinal can retain >90% potency for 6 months after opening, based on accelerated compatibility tests. Without encapsulation, that number can drop below 70% in 2 months. Always ask for PAO (Period After Opening) data supported by real‑time sensory and HPLC monitoring.
No. Both retinol and retinal are sold as cosmetic ingredients in the EU, US, and most of Asia. However, some jurisdictions (e.g., Canada) watch retinal more closely because of its proximity to retinoic acid. Check with your regulatory consultant, but OTC strength levels used in eye creams (≤0.05%) are generally not classified as drugs.
If you want to make a comparative performance claim, yes. An in‑vivo study with a head‑to‑head split‑face design is the strongest evidence. Many brands use instrumental measurements (corneometry, cutometer, or digital imaging) after 2 and 4 weeks. At minimum, have the manufacturer supply any existing third‑party data on the encapsulated retinal they propose.
Choosing between retinal and retinol isn’t a simple “better or worse” question—it’s a strategic decision that links your brand’s clinical story, price point, and supply chain complexity. For a tailored formulation recommendation including stability data, costing, and a sample kit that lets you test both options side by side, speak with our team.
With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.
